5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.34▼ | 0.34▼ | 0.34▼ | 0.35▼ | 0.33▼ |
MA10 | 0.34▼ | 0.35▼ | 0.35▼ | 0.34▼ | 0.33▲ |
MA20 | 0.34▲ | 0.34▲ | 0.34▲ | 0.34▼ | 0.46▼ |
MA50 | 0.34▼ | 0.35▼ | 0.36▼ | 0.32▲ | 0.82▼ |
MA100 | 0.37▼ | 0.35▼ | 0.34▲ | 0.48▼ | 1.74▼ |
MA200 | 0.35▼ | 0.32▲ | 0.34▲ | 0.76▼ | 5.56▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | 0.002▲ | 0.002▲ | 0.001▲ | 0.019▲ |
RSI | 50.017▲ | 49.786▼ | 49.319▼ | 48.511▼ | 34.033▼ |
STOCH | 13.209▼ | 42.921 | 42.921 | 45.288 | 32.784 |
WILL %R | -94.915▼ | -45.902 | -45.902 | -72.605 | -78.104▼ |
CCI | -44.406 | 24.710 | 24.704 | -7.328 | -22.722 |
Thursday, May 29, 2025 05:00 PM
The latest price target for Rallybio (NASDAQ:RLYB) was reported by Jones Trading on April 15, 2025. The analyst firm set a price target for $0.00 expecting RLYB to fall to within 12 months (a ...
|
Thursday, May 08, 2025 01:00 AM
Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases.
|
Wednesday, April 30, 2025 05:00 PM
Explore LyondellBasell Industries analyst ratings and price targets (NYSE:LYB) on Benzinga. Stay updated on expert opinions and forecasts for LYB stock.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
27/06/25 | 0.3625 | 0.3741 | 0.3326 | 0.3326 | 129,762 |
26/06/25 | 0.36 | 0.37 | 0.348 | 0.3625 | 192,872 |
25/06/25 | 0.3589 | 0.3796 | 0.34 | 0.3505 | 155,311 |
24/06/25 | 0.311 | 0.3755 | 0.3101 | 0.37 | 451,458 |
23/06/25 | 0.30 | 0.3441 | 0.30 | 0.3119 | 106,898 |
20/06/25 | 0.322 | 0.33 | 0.3065 | 0.3065 | 238,411 |
18/06/25 | 0.3162 | 0.3549 | 0.3162 | 0.3261 | 71,726 |
17/06/25 | 0.36 | 0.3729 | 0.32 | 0.338 | 141,748 |
16/06/25 | 0.3256 | 0.38 | 0.324 | 0.352 | 306,114 |
13/06/25 | 0.33 | 0.3441 | 0.3152 | 0.324 | 166,305 |
|
|
||||
|
|
||||
|
|